SAM
INSY

Shell Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Shell Asset Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-33,128
Closed -$153K – 1268
2019
Q1 		$153K Sell
33,128
-50,154
-60% -$237K ﹤0.01% 1135
2018
Q4 		$291K Sell
83,282
-7,000
-8% -$48.6K 0.01% 987
2018
Q3 		$910K Hold
90,282
– – 0.02% 714
2018
Q2 		$654K Sell
90,282
-4,845
-5% -$33.8K 0.01% 859
2018
Q1 		$575K Hold
95,127
– – 0.01% 872
2017
Q4 		$915K Hold
95,127
– – 0.02% 714
2017
Q3 		$845K Buy
95,127
+60,904
+178% +$628K 0.02% 679
2017
Q2 		$433K Hold
34,223
– – 0.01% 937
2017
Q1 		$360K Sell
34,223
-2,396
-7% -$25.5K 0.01% 973
2016
Q4 		$337K Sell
36,619
-320
-0.9% -$3.62K 0.01% 959
2016
Q3 		$436K Buy
+36,939
New +$561K 0.01% 901
2015
Q3 		– Sell
-94,799
Closed -$3.4M – 931
2015
Q2 		$3.4M Sell
94,799
-4,321
-4% -$135K 0.07% 290
2015
Q1 		$2.88M Sell
99,120
-292
-0.3% -$7.72K 0.05% 338
2014
Q4 		$2.1M Buy
+99,412
New +$1.97M 0.03% 466

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Shell Asset Management's INSY Position: Q2 2019 in Review

Shell Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 33,128 shares — an estimated $153K sold.

Shell Asset Management first reported a position in INSY in Q4 2014 and held it in 14 quarters. The position peaked at $3.4M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Shell Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Shell Asset Management sold 33,128 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $153K.
  • Shell Asset Management first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 14 quarters.
  • Shell Asset Management's Insys Therapeutics, Inc. position peaked at $3.4M in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Shell Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.